Reiser, Jochen

Factors associated with death in critically ill patients with coronavirus disease 2019 in the US

Gupta, S., Hayek, S. S., Wang, W., Chan, L., Mathews, K. S., Melamed, M. L., Brenner, S. K., Leonberg-Yoo, A., Schenck, E. J., Radbel, J., et al. (2020) · JAMA Internal Medicine

COVID-19 Clinical Research StudiesSepsis Diagnosis and Treatment

Cited by 957

Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation

Zewinger, S., Reiser, J., Jankowski, V., Alansary, D., Hahm, E., Triem, S., Klug, M., Schunk, S. J., Schmit, D., Kramann, R., et al. (2020) · Nature Immunology

Inflammasome and immune disordersImmune Response and Inflammation

Cited by 280

Mast cells, macrophages, and crown-like structures distinguish subcutaneous from visceral fat in mice

Altintas, M. M., Azad, A., Nayer, B., Contreras, G., Zaias, J., Faul, C., Reiser, J., & Nayer, A. (2011) · Journal of Lipid Research

Adipokines, Inflammation, and Metabolic DiseasesAdipose Tissue and Metabolism

Cited by 198

Targeting mTOR Signaling Can Prevent the Progression of FSGS

Zschiedrich, S., Bork, T., Liang, W., Wanner, N., Eulenbruch, K., Munder, S., Hartleben, B., Kretz, O., Gerber, S., Simons, M., et al. (2017) · Journal of the American Society of Nephrology

Renal Diseases and GlomerulopathiesPI3K/AKT/mTOR signaling in cancer

Cited by 76

Assay-related differences in SuPAR levels: implications for measurement and data interpretation

Vasbinder, A., Raffield, L. M., Gao, Y., Engstrom, G., Quyyumi, A. A., Reiner, A. P., Reiser, J., & Hayek, S. S. (2023) · Journal of Nephrology

Inflammation biomarkers and pathwaysClinical Laboratory Practices and Quality Control

Cited by 21